Fulcrum Therapeutics, Inc. (FULC)
12.80
-1.00
(-7.25%)
USD |
NASDAQ |
Dec 11, 16:00
13.24
+0.44
(+3.44%)
Pre-Market: 09:08
Fulcrum Therapeutics Free Cash Flow: -60.41M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agios Pharmaceuticals, Inc. | -414.09M |
| Biogen, Inc. | 2.262B |
| CorMedix, Inc. | 74.42M |
| Apellis Pharmaceuticals, Inc. | 78.64M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.19M |
| Cash from Investing (Quarterly) | 18.61M |
| Cash from Financing (Quarterly) | 0.064M |
| Free Cash Flow Per Share (Quarterly) | -0.2281 |
| Free Cash Flow to Equity (Quarterly) | -13.72M |
| Free Cash Flow to Firm (Quarterly) | -14.28M |
| Free Cash Flow Yield | -7.82% |